Preferred Label : Mycophenolate Sodium;
UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;
CAS number : WX877SQI1G;
Is substance : O;
UNII : WX877SQI1G;
InChIKey : DOZYTHNHLLSNIK-JOKMOOFLSA-M;
Origin ID : M0556402;
UMLS CUI : C1337395;
Currated CISMeF NLP mapping
Related record
Semantic type(s)
UMLS correspondences (same concept)
https://www.ansm.sante.fr/actualites/mycophenolate-lansm-rappelle-les-conditions-de-sa-prescription-et-de-sa-delivrance-car-son-utilisation-pendant-la-grossesse-persiste
2020
false
false
false
France
French
drug prescriptions
pregnancy
abnormalities, drug-induced
abortion, spontaneous
pharmacovigilance note
guidelines for drug use
risk management
mycophenolate mofetil
mycophenolate mofetil
Mycophenolate Sodium
Mycophenolate Sodium
mycophenolic acid
teratogens
immunosuppressive agents
immunosuppressive agents
Female of child bearing age (finding)
graft rejection
mycophenolic acid
mycophenolic acid
---
https://www.ansm.sante.fr/actualites/reduction-du-risque-lie-a-lexposition-au-mycophenolate-au-cours-de-la-grossesse-mise-a-disposition-des-guides-et-du-formulaire-daccord-de-soins-actualises
2018
false
false
false
France
French
pharmacovigilance note
teratogens
drugs, generic
mycophenolic acid
Mycophenolate Sodium
legislation, drug
drug prescriptions
patient education as topic
guidelines for drug use
pregnancy
risk management
risk
contraception
Mycophenolate Sodium
male contraception
female contraception
risk reduction
Drug-Related side effects and adverse reactions
Exposure during pregnancy
patients guideline
forms
Contraindications, Procedure
mycophenolic acid
mycophenolic acid
mycophenolic acid
risk reduction behavior
Contraindications, Drug
---
https://www.ansm.sante.fr/actualites/actualisation-des-mesures-de-reduction-du-risque-lie-a-lexposition-au-mycophenolate-au-cours-de-la-grossesse
2018
false
false
false
France
French
pharmacovigilance note
teratogens
drugs, generic
mycophenolic acid
Mycophenolate Sodium
legislation, drug
drug prescriptions
patient education as topic
guidelines for drug use
pregnancy
risk management
risk
contraception
Mycophenolate Sodium
male contraception
female contraception
risk reduction
Drug-Related side effects and adverse reactions
Contraindications, Procedure
mycophenolic acid
mycophenolic acid
mycophenolic acid
risk reduction behavior
Contraindications, Drug
---
nformation destinée aux chirurgiens cardio-thoraciques, chirurgiens digestifs, cardiologues,
pneumologues, néphrologues, gastroentérologues, spécialistes de médecine interne,
rhumatologues, urologues, anesthésistes-réanimateurs, dermatologues, neurologues,
gynécologues, médecins généralistes, pharmaciens hospitaliers et d’officine.
https://ansm.sante.fr/informations-de-securite/mycophenolate-mofetil-cellcept-r-et-ses-generiques-et-mycophenolate-sodique-myfortic-r-modification-des-recommandations-en-matiere-de-contraception
2018
false
false
false
France
French
pharmacovigilance note
teratogens
drugs, generic
mycophenolic acid
Mycophenolate Sodium
legislation, drug
drug prescriptions
patient education as topic
guidelines for drug use
pregnancy
risk management
patients guideline
risk
contraception
forms
Mycophenolate Sodium
male contraception
female contraception
risk reduction
Drug-Related side effects and adverse reactions
Contraindications, Procedure
mycophenolic acid
mycophenolic acid
mycophenolic acid
risk reduction behavior
Contraindications, Drug
---